Pascal immune to corneal biomechanics

Article

Intraocular pressure (IOP) measurements with the Pascal dynamic contour tonometer (PDCT) are relatively immune to changes in corneal biomechanics and pachymetry.

Intraocular pressure (IOP) measurements with the Pascal dynamic contour tonometer (PDCT) are relatively immune to changes in corneal biomechanics and pachymetry, according to a study published in the January issue of the American Journal of Ophthalmology.

Dr Jay Pepose and colleagues from the Pepose Vision Institute and the Washington University School of Medicine, St Louis, USA, conducted a prospective, non-randomized study to compare the preoperative and postoperative measurements of corneal biomechanical properties and IOP using Goldmann applanation tonometry (GAT), the ocular response analyser (ORA) and the PDCT in eyes undergoing myopic LASIK.

A total of 66 myopic eyes were measured for IOP before and after LASIK using the three devices in a randomized sequence. Metrics of corneal biomechanical properties were also recorded. After LASIK, there was a reduction in mean corneal pachymetry of 90.2 µm and in IOP measurements with GAT (Delta= -1.8±-2.8 mmHg; p<0.01), ORA-Goldmann (Delta= -4.6±-2.8 mmHg; p<0.01) and ORA-corneal compensated (Delta= -2.1±-2.6 mmHg; p<0.05). There was, however, no statistically significant difference between pre- and postoperative IOP measurements taken by PDCT (Delta= -0.5±-2.6 mmHg).

It was concluded that IOP measurements with PDCT are less likely to be affected by changes in corneal biomechanics and pachymetry after LASIK than if they are taken by GAT or ORA.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.